Company reports Q3 2024 XHANCE net revenue of $20.4 million, an increase of 3% compared to Q3 2023
Company reports positive inflection in new prescriptions of XHANCE starting in September
Read more at globenewswire.comOptinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
OPTINOSE INC
NASDAQ:OPTN (2/11/2025, 4:00:08 PM)
5.51
-0.19 (-3.33%)
OPTN Latest News and Analysis
a day ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
